Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
A trillion-dollar AI capex push by hyperscalers and chipmakers is fueling a fierce debate over whether the spending w...
Truist’s head of originations is pushing a curiosity-driven, AI-enabled approach to mortgage lending as rates and dem...
Costco faces a pivotal question for 2029: can it sustain double-digit earnings growth and margin resilience to lift C...
A 58-year-old solo consultant uses a cash balance plan atop a SOLO 401(K) to boost pre-tax retirement sheltering to o...
Ford posted solid Q1 results with rising revenue and a booming software business, while GM delivered a robust earning...
ICE launches an Encompass-integrated Fraud Monitor, centralizing fraud risk signals and property data. Early pilots i...
Memory stocks extend their surge with Micron rising about 7% and Western Digital up around 4%, as AI-driven demand su...
AI is accelerating frontline work even as executive teams struggle to adapt. Leaders must redesign decision-making to...
As XRP and Cardano chase a $5 milestone, traders weigh price paths, ETF momentum, and a major Cardano upgrade set for...
A fresh market thesis argues ethereum could outperform bitcoin this year as on-chain economics favor ETH, even as pri...
LoanCare announces a new private-label mortgage servicing platform designed to be embedded directly into lenders' dig...